The prostanoid-synthesizing enzyme cyclooxygenase-2 (COX-2) is expressed in selected cerebral cortical neurons and is involved in synaptic signaling. We sought to determine whether COX-2 participates in the increase in cerebral blood flow produced by synaptic activity in the somatosensory cortex. In anesthetized mice, the vibrissae were stimulated mechanically, and cerebral blood flow was recorded in the contralateral somatosensory cortex by a laser-Doppler probe. We found that the COX-2 inhibitor NS-398 attenuates the increase in somatosensory cortex blood flow produced by vibrissal stimulation. Furthermore, the flow response was impaired in mice lacking the COX-2 gene, whereas the associated increase in whiskerbarrel cortex glucose use was not affected. The increases in cerebral blood flow produced by hypercapnia, acetylcholine, or bradykinin were not attenuated by NS-398, nor did they differ between wild-type and COX-2 null mice. The findings provide evidence for a previously unrecognized role of COX-2 in the mechanisms coupling synaptic activity to neocortical blood flow and provide an insight into one of the functions of constitutive COX-2 in the CNS.
Cyclooxygenase-2 (C OX-2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes from arachidonic acid (for review, see Vane et al., 1998) . In some organs, C OX-2 is not present in the normal state, but its expression is induced by inflammatory stimuli or mitogens (for review, see Dubois et al., 1998) . In brain, however, C OX-2 is constitutively expressed and is localized to a restricted population of excitatory neurons, wherein it is enriched in dendritic arborizations and spines (Yamagata et al., 1993; Breder et al., 1995; Kaufmann et al., 1996) . The role that C OX-2 plays in normal brain f unction has yet to be elucidated. In the adult cerebral cortex, neuronal COX-2 expression is upregulated by synaptic activity (Yamagata et al., 1993) and, in the developing nervous system of the rat, COX-2 expression increases at a time when activity-dependent synaptic remodeling occurs (Kaufmann et al., 1996) . These observations, in concert with its synaptic localization, have suggested that COX-2 is involved in activity-dependent processes and synaptic signaling (Kaufmann et al., 1996) .
Synaptic activity is one of the critical factors controlling the distribution of cerebral blood flow (CBF) among the different brain regions. Thus, regional CBF is dynamically regulated to closely match the changes in f unctional activity of each brain region (for review, see Raichle, 1987; Woolsey et al., 1996) . For example, when neural activity increases in the somatosensory or visual cortex, the amount of flow reaching these regions increases in proportion to the degree of activation (Fox and Raichle, 1984; Ginsberg et al., 1987; Greenberg et al., 1979 ) (for review, see Raichle, 1987) . The spatial and temporal correspondence between neural activity and CBF is so accurate that changes in CBF are routinely used to map brain function in humans (Raichle, 1998) . Although the mechanisms that link synaptic activity to local blood flow have been investigated for over a century, they still remain to be elucidated in full (Lou et al., 1987; Iadecola, 1993; Woolsey et al., 1996) . The observation that COX-2, an enzyme whose reaction products are vasoactive (Ellis et al., 1979; Leffler and Busija, 1987; Wei et al., 1996) , is closely associated with postsynaptic elements of excitatory neurons, raises the possibility that COX-2 plays a role in the mechanisms coupling synaptic activity to blood flow in brain.
In the present study, we sought to determine whether COX-2 is involved in the increases in CBF that accompany neural activity. Using activation of the rodent whisker-barrel cortex as a model of functional hyperemia (Greenberg et al., 1979; Woolsey and Rovainen, 1991) , we found that the selective COX-2 inhibitor NS-398 attenuates the increase in neocortical blood flow produced by vibrissal stimulation. Furthermore, the hyperemic response is impaired in mutant mice lacking COX-2, whereas the associated increase in glucose use, a variable that reflects neural activity, is not affected. The findings unveil a previously unrecognized role of COX-2 in the mechanisms linking synaptic activity to local blood flow in the somatosensory cortex and provide an insight into one of the potential functions of COX-2 in the normal brain.
MATERIALS AND METHODS Animals
C57BL /6 mice were obtained from The Jackson Laboratory (Bar Harbor, Maine). C OX-2 null mice [homozygous (Ϫ/Ϫ) mice and their wild-type (ϩ/ϩ) littermates] were obtained from a colony established at the University of Minnesota from breeding pairs provided by one of the authors (S. Morham) (Morham et al., 1995) . Mice were back-crossed to C57BL /6 mice six to eight times and were studied at age 2-3 months. E xperiments were performed in age-matched littermates (C OX-2 ϩ/ϩ and Ϫ/Ϫ) to minimize confounding effects deriving from the genetic background of the mice. The genotype of all C OX-2 mice was determined by PCR (Morham et al., 1995) . C OX-2 mRNA is not detectable in the brain of C OX-2 Ϫ/Ϫ mice (C. Iadecola, S. Morham, and M. E. Ross, unpublished observations) .
Cerebral blood flow during vibrissal stimulation
Techniques used for studying the cerebral circulation in mice were similar to those described previously (Z hang et al., 1997; Yang et al., 1998; Iadecola et al., 1999) . Mice were anesthetized with urethane (750 mg / kg) and chloralose (50 mg / kg). The trachea was intubated, and mice were artificially ventilated with an oxygen -nitrogen mixture. One of the femoral arteries was cannulated for recording of arterial pressure and collection of blood samples. Rectal temperature was maintained at 37°C using a thermostatically controlled rectal probe connected to a heating lamp. End-tidal C O 2 , monitored by a C O 2 analyzer (C apstar-100; C W I Inc.), was maintained at 2.6 -2.7% (pC O 2 ϭ 33-35 mmHg; dead-space ventilation included) (Z hang et al., 1997) (Table 1) . A small craniotomy (2 ϫ 2 mm) was performed to expose the whisker-barrel area of the somatosensory cortex, the dura was removed, and the site was superf used with Ringer's solution (37°C; pH 7.3-7.4) (Z hang et al., 1997) . CBF was continuously monitored at the site of superf usion with a laser-Doppler probe (Vasamedic, St. Paul, M N) positioned stereotaxically on the cortical surface. The right vibrissae were cut to a length of 5-10 mm and stimulated for 1 min by gently stroking them (3-4 Hz) with a cottontipped applicator. The left vibrissae were cut as short as possible to avoid unwanted stimulation (Adachi et al., 1994) . Vibrissal stimulation produced increases in CBF that reached a stable plateau (Fig. 1) . CBF increases, expressed as percentage increase, were computed as the ratio of CBF at the level of the plateau and baseline CBF before vibrissal stimulation (Z hang et al., 1997; Yang et al., 1998; Iadecola et al., 1999) . T wo or three vibrissal stimulation trials, separated by 10 min intervals, were averaged for each experimental condition tested. Z ero values for CBF were obtained after the heart was stopped by an overdose of halothane at the end of the experiment.
Cerebral glucose use during vibrissal stimulation
C erebral glucose use (CGU) was determined in awake, lightly restrained C OX-2 ϩ/ϩ and Ϫ/Ϫ mice by a modification of the 14 C -2-deoxyglucose (2-DG) method (Sokoloff et al., 1977; Meibach et al., 1980) . Under halothane anesthesia, one of the femoral arteries was cannulated and used for recording of arterial pressure (Table 1 ) and collection of blood samples. Wounds were treated with a 2% lidocaine ointment and sutured. Mice were allowed to recover from anesthesia for 3-4 hr and placed in a loosely fitting restraining cylinder with an anterior opening to expose the face and whiskers. The right vibrissae were stroked for 1 min before 2-DG injection. Vibrissal stimulation continued throughout the 45 min measurement period.
14 C -labeled 2-DG (20 C i /100 gm in 1 ml of 0.9% NaC l; N EN, Boston, M A) was injected intraperitoneally, and ϳ60 l of arterial blood were collected 1, 5, 7, 10, 15, 20, 25, 35 , and 45 min later. One blood sample was taken before injection of 2-DG. These sampling times were selected in preliminary experiments to accurately resolve the arterial concentration time course of the tracer. Blood samples were centrif uged and stored on ice. The volume of blood removed was replaced with normal saline. Blood sampling reduced mean arterial pressure from 101 Ϯ 4 mmHg to 70 Ϯ 6 in C OX-2 ϩ/ϩ mice and from 106 Ϯ 4 to 68 Ϯ 4 in C OX-2 Ϫ/Ϫ mice ( p Ͻ 0.05). However, such hypotension is unlikely to lead to cerebral hypoperf usion because arte- rial pressure is still within the autoregulated range of CBF in this preparation . Techniques for determination of tissue 2-DG concentration by quantitative autoradiography have been described previously (Iadecola and Xu, 1994) and are only summarized. After collection of the last blood sample, mice were deeply anesthetized with halothane and decapitated. Brains were rapidly removed and frozen in isopentane cooled to Ϫ30°C. Serial sections (20 m) were cut through the brain using a cryostat (Hacker-Bright; Hacker Instruments, Fairfield, NJ), mounted on glass slides, and apposed to x-ray film (Sterling Diagnostic Imaging Inc., Newark, DE) together with calibrated 14 C standards (Iadecola et al., 1996) . Fourteen days later, the film was developed, and the optical density (OD) of regions of interest was determined bilaterally on four adjacent sections using a computerized image analyzer (MCI D system; Imaging Research Inc., St. C atharines, Ontario, C anada). OD was transformed in 14 C concentration (nanocuries per gram) using the standards on the film (Iadecola and Xu, 1994) . Radioactivity (nanocuries per gram) of plasma samples was determined by liquid scintillation counting (Iadecola and Xu, 1994) . Plasma glucose was measured using a glucose analyzer (Beckman Instruments, Fullerton, CA) ( Table 1 ). CGU (mol / 100 gm /min) was calculated from the OD of the regions of interest and the arterial time course of 2-DG using the equation developed by Sokoloff et al. (1977) .
E xperimental protocol for CBF studies
Effect of NS-398 on the increase in CBF produced by vibrissal stimulation in C57BL/6 mice. The cranial window was superf used with Ringer's, and baseline CBF responses to vibrissal activation were obtained. The superf usion solution was then changed to Ringer's containing increasing concentrations of the C OX-2 inhibitor NS-398 (10 -300 M; C ayman Chemicals, Ann Arbor, M I) (Futaki et al., 1993; Seibert et al., 1994) .
Responses to whisker stimulation were tested after each concentration of NS-398 was applied for 40 min. This time point was selected on the basis of preliminary experiments in which the time course of the effect of NS-398 on CBF responses to vibrissal stimulation was studied (data not shown).
Effect of NS-398 on the increase in CBF produced by other vasodilators in C57BL/6 mice. The cranial window was superf used with Ringer's, and baseline CBF responses to topical application of acetylcholine (ACh) (10 M; Sigma, St. L ouis, MO) or bradykinin (BK) (50 M; Sigma) were tested. Agents were superf used on the cerebral cortex for 3-5 min at concentrations that produce 50% of maximal responses . The vasodilation produced by arterial hypercapnia was also tested. Hypercapnia (pC O 2 ϭ 50 -60 mmHg) was produced by introducing C O 2 through the circuit of the ventilator and was induced for 2-3 min. After the hypercapnia challenge was completed, pC O 2 was returned to normocapnia.
Increases in CBF produced by vibrissal stimulation in COX-2 null mice. In these experiments, the vibrissae were stimulated in C OX-2 Ϫ/Ϫ and C OX-2 ϩ/ϩ mice, and the evoked changes in CBF were recorded. CBF responses to topical application of ACh or BK or to arterial hypercapnia were studied using methods described above. In some experiments, the effect of NS-398 on the CBF response evoked by vibrissal stimulation was tested in C OX-2 ϩ/ϩ and Ϫ/Ϫ mice. NS-398 was applied for 40 min at a concentration of 100 M.
Data analysis
Data in text and figures are expressed as means Ϯ SE. T wo-group comparisons were analyzed by the two-tailed t test for independent samples. Multiple comparisons were evaluated by the ANOVA and T ukey's test. p Ͻ 0.05 was considered statistically significant.
RESULTS

Effect of NS-398 on the increase in CBF produced by vibrissal stimulation
In these experiments, we studied the effect of the COX-2 inhibitor NS-398 on the increases in CBF produced by vibrissal stimulation in C57BL/6 mice. During superfusion with Ringer's, vibrissal stimulation increased CBF in the contralateral somatosensory cortex by 30 Ϯ 1% (n ϭ 6), an increase comparable with that reported previously in this preparation (Ma et al., 1996) . The increases in CBF reached a stable plateau within 10 -20 sec of stimulation (Fig. 1) . Superfusion with NS-398 (10 -300 M) did not influence resting CBF [before NS-398 (100 M), 20.7 Ϯ 0.5 perfusion units; after NS-398, 20.6 Ϯ 0.7; p Ͼ 0.05], but it attenuated the increase in CBF produced by vibrissal stimulation substantially (Figs. 1, 2) . The effect of NS-398 was dosedependent and reached a maximum at 100 M (Ϫ47 Ϯ 7%; p Ͻ 0.01). In contrast, NS-398 did not alter the flow increase produced by hypercapnia ( p Ͼ 0.05) (Fig. 2) or by topical application of ACh and BK ( p Ͼ 0.05) (Fig. 3) .
Effect of vibrissal stimulation on CBF in COX-2 null mice
To provide additional evidence that COX-2 is involved in the flow response evoked by somatosensory activation, COX-2 null mice were studied. In COX-2 Ϫ/Ϫ mice, the increase in CBF produced by vibrissal stimulation was markedly reduced compared with COX-2 ϩ/ϩ littermates (Ϫ37 Ϯ 2%) (Figs. 1, 4) . However, the increases in CBF produced by hypercapnia or topical application of ACh and BK were not affected (Figs. 4, 5) . In COX-2 ϩ/ϩ, topical superfusion of NS-398 (100 M) reduced the CBF response to vibrissal stimulation (Ϫ37 Ϯ 1%; p Ͻ 0.01) (Fig. 4) without attenuating responses to hypercapnia, ACh, or BK (Figs. 4, 5) ( p Ͼ 0.05). However, in COX-2 Ϫ/Ϫ mice, NS-398 failed to influence the CBF response to somatosensory activation (Fig. 4) .
Effect of vibrissal stimulation on CGU in COX-2 null mice
In COX-2 ϩ/ϩ mice, CGU ranged from 64 Ϯ 7 mol/100 gm/min in the left corpus callosum to 260 Ϯ 38 in the left inferior colliculus (Table 2, C OX-2 ϩ/ϩ column). Vibrissal stimulation increased CGU selectively in the contralateral somatosensory cortex (ϩ39 Ϯ 5%), contralateral ventrobasal thalamus (ϩ41 Ϯ 11%), and ipsilateral trigeminal nucleus (ϩ54 Ϯ 15%) ( p Ͻ 0.01) ( Table 2 ). In C OX-2 Ϫ/Ϫ mice, resting CGU was not different from that of C OX-2 ϩ/ϩ mice in any of the brain regions studied (Fig. 6, Table 2 ) ( p Ͼ 0.05). Furthermore, the increases in CGU in somatosensory relay nuclei were similar to those observed in COX-2 ϩ/ϩ mice (Table 2) .
DISCUSSION
We sought to determine whether the prostanoid-synthesizing enzyme C OX-2 is involved in the increases in CBF produced by functional activation. Using a mouse model of somatosensory activation, we found that the COX-2 inhibitor NS-398 attenuates the increase in somatosensory cortex blood flow produced by vibrissal stimulation. The attenuation is related to the concentration of the inhibitor and is independent of effects on resting CBF. Interestingly, NS-398 did not attenuate the increase in CBF produced by hypercapnia, a response that is not linked to neural activity (Iadecola et al., 1987; Fabricius and Lauritzen, 1994) . Furthermore, NS-398 did not alter the increase in CBF produced by topical application of ACh or BK, vasodilators that act by releasing vasoactive factors from the endothelium (Rosenblum, 1986; Mayhan, 1996; . The findings indicate that NS-398 attenuates vasodilator responses mediated by neural activation, and they are consistent with the exclusive neuronal localization of COX-2 in the normal brain (Yamagata et al., 1993; Breder et al., 1995; Kaufmann et al., 1996) .
To provide independent evidence that COX-2 is involved in the mechanisms of functional hyperemia, mice with a null mutation of the COX-2 gene were studied (Morham et al., 1995) . We found that the increase in CBF produced by vibrissal stimulation is attenuated in COX-2 Ϫ/Ϫ mice, whereas responses to hypercapnia and to topical application of ACh or BK were preserved. To rule out the possibility that the attenuation in functional hyperemia resulted from a reduction in neural activation during vibrissal stimulation, we studied the effect of vibrissal stimulation on CGU, a reliable marker of synaptic activity (Yarowsky et al., 1983) . It was found that the increase in CGU in the whiskerbarrel cortex and in other somatosensory relay stations did not differ between C OX-2 ϩ/ϩ and Ϫ/Ϫ mice. Therefore, the attenuation in f unctional hyperemia in C OX-2 Ϫ/Ϫ mice cannot be attributed to a reduction in the intensity of neural activation. However, the possibility that the time course of the activation differs between C OX-2 ϩ/ϩ and Ϫ/Ϫ mice cannot be ruled out, because the 2-DG method has a limited temporal resolution. Thus, the 2-DG method provides an average of CGU during the 45 min measurement period, albeit heavily weighted toward the first 10 min (Sokoloff et al., 1977) . The findings in C OX-2 null mice, in concert with the pharmacological data with NS-398, provide strong evidence that C OX-2 is involved in the mechanisms coupling synaptic activity to blood flow in brain.
The findings of the present study cannot be attributed to secondary effects on CBF resulting from differences in physiological variables. Arterial pressure and blood gases were carefully monitored and did not differ among the groups of mice studied. In addition, the effect of NS-398 is unlikely to result from a nonspecific blockade of all vasodilator responses, because this inhibitor did not attenuate the CBF response to hypercapnia, ACh, or BK. Furthermore, the observation that NS-398 does not alter the increase in CBF produced by vibrissal stimulation in COX-2 null mice supports the selectivity and specificity of the effects of NS-398 in this model. A major drawback of studies using null mice is that compensatory changes initiated by the missing gene product may alter the normal physiology of the mouse (Gerlai, 1996) . Furthermore, because most null mice have a mixed genetic background (C57BL/6 and SV129), the possibility that the observed effects result from strain differences cannot be ruled out (Choi, 1997) . However, these concerns do not apply to the present study, because acute pharmacological inhibition of COX-2 reproduced in full the cerebrovascular "phenotype" of the COX-2 null Figure 4 . Effect of NS-398 on the increases in CBF produced by vibrissal stimulation ( A) or hypercapnia ( B) in homozygous C OX-2 null mice (Ϫ/Ϫ) or in wild-type littermates (ϩ/ϩ). The response to whisker stimulation is attenuated in C OX-2 null mice ( p Ͻ 0.01). Furthermore, NS-398 (100 M) attenuated the response in C OX-2 ϩ/ϩ but not in COX-2 Ϫ/Ϫ mice. The response to hypercapnia ( B) is not affected in COX-2 Ϫ/Ϫ null mice and is not attenuated by NS-398 in either C OX-2 Ϫ/Ϫ or ϩ/ϩ mice ( p Ͼ 0.05). mice. Therefore, the reduced CBF response to vibrissal stimulation in C OX-2 null mice cannot be attributed to heterogeneity of the genetic background or to compensatory changes in cerebrovascular physiology resulting from C OX-2 deletion. In addition, the fact that acute C OX-2 inhibition with NS-398 reproduces the cerebrovascular effects of C OX-2 deletion rules out the possibility that alterations in neuronal development resulting from lack of COX-2 are responsible for the reduction in the hyperemic response.
The mechanisms regulating the cerebral circulation during synaptic activity have been investigated extensively over the past century. The prevailing view is that working brain cells release vasoactive agents that spread to local blood vessels and produce vasodilation (Iadecola, 1993; Woolsey et al., 1996) . Over the years, a wide variety of factors, including Hϩ and K ϩ ions, CO 2 , hypoxia, adenosine, neurotransmitters, and neuropeptides, have been proposed to play a role in the coupling between synaptic activity and blood flow (Kuschinsky et al., 1972; Leniger-Follert, 1984; Yaksh et al., 1987; Ko et al., 1990 ) (for review, see Edvinsson et al., 1993) . However, as discussed in detail previously (Edvinsson et al., 1993; Iadecola, 1993; Lou et al., 1987) , conclusive evidence that these agents are involved in the vasodilation initiated by functional activity is lacking. Recently, neurons containing nitric oxide synthase (NOS) have been proposed to be involved in the mechanisms coupling synaptic activity to blood flow (Gally et al., 1990; Iadecola, 1993) . Initial observations supported this hypothesis by demonstrating that pharmacological inhibition of NOS in somatosensory cortex attenuates the in- crease in CBF produced by vibrissal stimulation (Northington et al., 1992; Dirnagl et al., 1993; Irikura et al., 1994) . However, subsequent findings have challenged this idea. Mutant mice lacking neuronal NOS (nNOS) have a normal neocortical flow increase in response to vibrissal stimulation (Ma et al., 1996) , suggesting that nNOS is not required for the hyperemic response. Furthermore, other studies have indicated that NO acts more as a "permissive" factor, facilitating the action of other vasodilators, than as the mediator of vasodilation (Niwa et al., 1993; Lindauer et al., 1999 ) (for review, see Iadecola, 1999) . Therefore, the presence of NO is not an absolute requirement for the CBF increases evoked by synaptic activity. In contrast, we have shown here that acute inhibition of COX-2 by NS-398 and deletion of C OX-2 by gene-targeting approaches produce comparable attenuations of the increase in CBF evoked by somatosensory activation. Therefore, the presence of COX-2 is absolutely required for the f ull expression of the vasodilation. These data demonstrate that C OX-2 plays a critical role in the mechanisms coupling synaptic activity to blood flow and provide functional evidence for a participation of C OX-2 in activitydependent processes in the C NS.
The mechanisms by which C OX-2 influences CBF during neural activity remain to be defined. In the normal rodent brain, COX-2 is expressed exclusively in neurons (Yamagata et al., 1993; Breder et al., 1995; Kaufmann et al., 1996) . It is, therefore, likely that neuronal COX-2 is involved in the coupling between synaptic activity and blood flow. One possibility is that COX-2 is activated during neuronal depolarization and that COX-2 reaction products, either directly or through another agent, influence vascular tone and produce vasodilation. Prostaglandin E2 and prostacyclin, metabolites of the COX-2 reaction product prostaglandin H2 (Brock et al., 1999) , or superoxide, the other product of COX-2, are potent cerebrovasodilators (Ellis et al., 1979; Leffler and Busija, 1987; Wei et al., 1996) . It would also be of interest to determine whether neurons containing COX-2 have close associations with cerebral blood vessels. For example, central neurons containing NOS, dopamine, ACh, and vasoactive intestinal polypeptide have processes closely apposed to cerebral blood vessels (Eckenstein and Baughman, 1984; Iadecola et al., 1993; Vaucher and Hamel, 1995; Krimer et al., 1998) . However, most morphological data on the localization of COX-2 in neurons were obtained in rats, and it would be important to determine whether a similar localization is present also in other species. Irrespective of the specific COX-2 reaction product(s) involved in the vasodilation and the relationships of COX-2 neurons to blood vessels, the present results are noteworthy because they provide, for the first time, evidence that COX-2 is involved in the mechanisms regulating CBF during synaptic activity.
In conclusion, we have demonstrated that pharmacological inhibition of COX-2 with NS-398 attenuates the increase in CBF produced by somatosensory activation. The increase in CBF is also attenuated in mice lacking COX-2. Vasodilator responses of the cerebral circulation that do not depend on neuronal activity were not influenced by NS-398 and were preserved in COX-2 null mice. The attenuation of the CBF response in null mice cannot be attributed entirely to a reduction in the intensity of activation produced by vibrissal stimulation. The findings unveil a critical role of COX-2 in the mechanisms coupling synaptic activity to neocortical blood flow and provide an insight into one of the functions of constitutive COX-2 in the CNS. Figure 6 . Effect of vibrissal stimulation on CGU in the somatosensory cortex of COX-2 null mice. Vibrissal stimulation produces comparable increases in CGU in COX-2 wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice. See Table 2 for group values.
